Showing results (361-370 of 373) with videos related to

Sort By:
Pageof 38
Nature Communications|May 2, 2018
Multi-omics profiling of younger Asian breast cancers reveals distinctive molecular signaturesZhengyan Kan, Ying Ding, Jinho Kim, et al.
Plos Genetics|April 13, 2011
Cancer-associated splicing variant of tumor suppressor AIMP2/p38: pathological implication in tumorigenesisJin Woo Choi, Dae Gyu Kim, Al-Eum Lee, et al.
Eclinicalmedicine|February 16, 2024
Role of invasive mediastinal nodal staging in survival outcomes of patients with non-small cell lung cancer and without radiologic lymph node metastasis: a retrospective cohort studyHong Kwan Kim, Yeong Jeong Jeon, Sang-Won Um, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 8, 2015
Multinational Randomized Phase III Trial With or Without Consolidation Chemotherapy Using Docetaxel and Cisplatin After Concurrent Chemoradiation in Inoperable Stage III Non-Small-Cell Lung Cancer: KCSG-LU05-04Jin Seok Ahn, Yong Chan Ahn, Joo-Hang Kim, et al.
Pathology|November 1, 2022
The Ring Study: an international comparison of PD-L1 diagnostic assays and their interpretation in non-small cell lung cancer, head and neck squamous cell cancer and urothelial cancerSung-Liang Yu, Yi-Jing Hsiao, Wendy A Cooper, et al.
Gut|August 11, 2016
Integrated genomic analysis of recurrence-associated small non-coding RNAs in oesophageal cancerHee-Jin Jang, Hyun-Sung Lee, Bryan M Burt, et al.
Journal for Immunotherapy of Cancer|February 14, 2024
Inflamed immune phenotype predicts favorable clinical outcomes of immune checkpoint inhibitor therapy across multiple cancer typesJeanne Shen, Yoon-La Choi, Taebum Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 2022
Artificial Intelligence-Powered Spatial Analysis of Tumor-Infiltrating Lymphocytes as Complementary Biomarker for Immune Checkpoint Inhibition in Non-Small-Cell Lung CancerSehhoon Park, Chan-Young Ock, Hyojin Kim, et al.
Nature Communications|December 3, 2020
Chemotherapy induces dynamic immune responses in breast cancers that impact treatment outcomeYeon Hee Park, Samir Lal, Jeong Eon Lee, et al.
Genome Medicine|July 20, 2023
Longitudinal multi-omics study of palbociclib resistance in HR-positive/HER2-negative metastatic breast cancerYeon Hee Park, Seock-Ah Im, Kyunghee Park, et al.
Pageof 38